Dow Up 0.11% Nasdaq Up 0.50%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.32 0.03(2.33%) Aug 29, 4:00PM EDT
Prev Close:1.29
Open:1.30
Bid:1.05 x 200
Ask:2.30 x 200
1y Target Est:1.67
Beta:0.71
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.26 - 1.33
52wk Range:1.00 - 2.36
Volume:356,855
Avg Vol (3m):1,067,120
Market Cap:68.33M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVEOUp 2.33%68.33M
AMGN105.87B
PFE186.36B
RHHBY248.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback